Stock Price Prediction

SLGL stock is currently trading at $0.9540, down significantly by 42.2% in pre-market trading, following a sharp 285% surge earlier. The bearish sentiment stems from profit-taking and potential concerns over the sustainability of its recent rally. However, heightened investor interest in biotech stocks, including SLGL, suggests potential volatility and speculative opportunities.

SLGL stock is currently trading at $0.7746, reflecting a sharp decline of over 40% recently. The bearish view stems from its weak financial performance and lack of positive catalysts, as evidenced by its low trading volume and poor market sentiment. Additionally, the stock's inability to sustain gains after prior spikes suggests limited investor confidence.

The market consensus for SLGL's revenue in the upcoming quarter is projected to be approximately $1.25M USD.

The market consensus for SLGL's eps in the upcoming quarter is projected to be approximately $0.17 USD.